Showing results (141-150 of 560) with videos related to
Sort By:
Pageof 56
Oncotargets and Therapy|August 16, 2016
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinomaMichael Davidson, Elizabeth C Smyth, David CunninghamLeukemia & Lymphoma|May 24, 2012
Diagnosis and management of rare gastrointestinal lymphomasEliza A Hawkes, Andrew Wotherspoon, David CunninghamEuropean Journal of Cancer (Oxford, England : 1990)|June 28, 2005
The frequency and pattern of cardiotoxicity observed with capecitabine used in conjunction with oxaliplatin in patients treated for advanced colorectal cancer (CRC)Matthew Ng, David Cunningham, Andrew R NormanCurrent Treatment Options in Oncology|April 2, 2016
Esophagogastric Adenocarcinoma: Is More Chemotherapy Better?Elisa Fontana, Elizabeth C Smyth, David CunninghamAmerican Journal of Surgery|March 25, 2009
Surgical outcomes following pancreatic resection at a low-volume community hospital: do all patients need to be sent to a regional cancer center?John David Cunningham, Nancy O'Donnell, Paul StarkerImmunotherapy|December 20, 2014
Potential role of rilotumumab in the treatment of gastric cancerTom Waddell, Sing Yu Moorcraft, David CunninghamOncotargets and Therapy|June 25, 2014
Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitorsElizabeth C Smyth, Francesco Sclafani, David CunninghamDrugs|March 30, 2011
Optimal therapeutic strategies for resectable oesophageal or oesophagogastric junction cancerBranislav Bystricky, Alicia F C Okines, David CunninghamThe International Journal on Drug Policy|July 26, 2016
Supportive housing and surveillanceJade Boyd, David Cunningham, Solanna Anderson, et al.Human Genetics|August 31, 2017
SMN regulation in SMA and in response to stress: new paradigms and therapeutic possibilitiesCatherine E Dominguez, David Cunningham, Dawn S ChandlerPageof 56